Hyperthermia treatment for cancer, also known as thermal therapy, is a form of cancer treatment that uses heat to destroy or damage cancer cells. It involves exposing the cancer cells to high temperatures, typically ranging from 40 to 45 degrees Celsius, which can cause the cancer cells to die or become more sensitive to radiation or chemotherapy.
Global hyperthermia treatment for cancer market revenue is projected to register a CAGR of 6.1% during the forecast period (2017–2025). The global hyperthermia treatment for cancer market is estimated to be valued at US$ 99 million in the year 2017 and is slated to reach a market value close to US$ 160 million in the year 2025.
Request For Free Sample Report of “Hyperthermia Treatment for Cancer Market”@ https://www.persistencemarketresearch.com/samples/14632
The global market for hyperthermia treatment for cancer is expected to grow in the coming years. This can be attributed to several factors, including an increasing incidence of cancer worldwide, advancements in technology that have made hyperthermia more effective and precise, and the growing use of hyperthermia in combination with other cancer treatments.
Another factor driving the market is the advancements in technology that have made hyperthermia more effective and precise. Newer hyperthermia machines are able to deliver heat more precisely to the tumor, which allows for a higher rate of cancer cell destruction while minimizing damage to surrounding healthy tissue. Additionally, newer machines are able to deliver heat at higher temperatures, which increases the effectiveness of the treatment.
Companies
- Celsius42+ GmbH
- Pyrexar Medical Inc.
- Oncothermia
- Hydrosun GmbH
- Yamamoto Vinita Co., Ltd
- Andromedic Srl
- Haifu Medical Technology Co. Ltd
Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/14632
The growing use of hyperthermia in combination with other cancer treatments is also expected to drive the market. Hyperthermia has been shown to increase the effectiveness of radiation therapy and chemotherapy, and as a result, more and more oncologists are using the two treatments in combination. This is expected to lead to an increase in the number of patients receiving hyperthermia treatment.
In conclusion, the global market for hyperthermia treatment for cancer is expected to grow in the coming years, driven by an increasing incidence of cancer worldwide, advancements in technology, and the growing use of hyperthermia in combination with other cancer treatments. As the market continues to grow, more research and development is needed to improve the effectiveness and availability of hyperthermia treatment for cancer patients around the world.
Global Hyperthermia Treatment for Cancer Market Analysis and Forecast, By Device Type
Microwave Hyperthermia Device segment is estimated to account for over 40% revenue share of the global hyperthermia treatment for cancer market by 2017 end and is expected to lose 99 basis points in its market share by 2025 over 2017. Ultrasound Hyperthermia Device segment is estimated to account for close to 25% revenue share of the global hyperthermia treatment for cancer market by 2017 end and is expected to gain 139 basis points in its market share by 2025 over 2017.
Among the device types, the Short-wave Hyperthermia Device segment is projected to register the highest CAGR of 7.0% in terms of value in the global hyperthermia treatment for cancer market during the forecast period.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/14632
Market Taxonomy
| By Device Type |
|
| By End User |
|
| By Application |
|
For More Premium Insights, Check out the Link:
Bladder Cancer Treatment Drugs market
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
Japan
Persistence Market Research
1-2-1 Kinshi Arca Central Building 14/F Tokyo, 130-0013 Japan
Call 0800-222-1088
United States
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com